Zhejiang Hisoar Pharmaceutical Co.,Ltd.’s Net Profit Dropped 51.6% in First Quarter of 2023

Zhejiang Hisoar Pharmaceutical Co.,Ltd. (浙江海翔药业股份有限公司) (002099.SZ) reported a net profit of 41.8 million yuan in the first quarter of 2023, down 51.6% year-on-year.

Meanwhile, the company posted 634 million yuan in revenue, down 21.2% year-on-year.

At the end of the reporting period, it had 9.1 billion yuan in total assets and 2.9 billion yuan in total liabilities, with a liability-to-asset ratio of 32.2%.